Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-n-((s)-4-amino-2-hydroxybutyryl)dibekacin
2. 4-amino-2-hydroxybutylyldibekacin
3. Arbekacin
4. Habekacin
5. Me1100
1. Habekacin
2. 104931-87-5
3. Arbekacin Sulphate
4. Arbekacin Sulfate [jan]
5. D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-n'-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)-, Sulfate (salt)
6. Chebi:31233
7. G7395hz992
8. Npc-14
9. (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-4-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric Acid
10. Habekacin (tn)
11. (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-2-(3-amino-3-deoxy-alpha-d-glucopyranosyloxy)-4-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide Sulfate
12. Ncgc00167530-01
13. Habekacinxsulfate
14. Habekacin Sulfate
15. Unii-g7395hz992
16. Habekacin Xsulfate
17. Arbekacin Sulfate (jp17)
18. Dsstox_cid_26694
19. Dsstox_rid_81828
20. Dsstox_gsid_46694
21. Schembl445497
22. Arbekacin Sulfate [mi]
23. Chembl3184482
24. Dtxsid0046694
25. Arbekacin Sulfate [mart.]
26. Arbekacin Sulfate [who-dd]
27. Tox21_112527
28. 1665-rb
29. Cas-104931-87-5
30. A-8298
31. D01523
32. Arbekacin Sulfate, Antibiotic For Culture Media Use Only
33. D-streptamine, O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-n1-((2s)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, Sulfate
| Molecular Weight | 650.7 g/mol |
|---|---|
| Molecular Formula | C22H46N6O14S |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 10 |
| Exact Mass | 650.27927134 g/mol |
| Monoisotopic Mass | 650.27927134 g/mol |
| Topological Polar Surface Area | 380 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 839 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 14 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
A Habekacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Habekacin, including repackagers and relabelers. The FDA regulates Habekacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Habekacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Habekacin supplier is an individual or a company that provides Habekacin active pharmaceutical ingredient (API) or Habekacin finished formulations upon request. The Habekacin suppliers may include Habekacin API manufacturers, exporters, distributors and traders.
click here to find a list of Habekacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Habekacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Habekacin active pharmaceutical ingredient (API) in detail. Different forms of Habekacin DMFs exist exist since differing nations have different regulations, such as Habekacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Habekacin DMF submitted to regulatory agencies in the US is known as a USDMF. Habekacin USDMF includes data on Habekacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Habekacin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Habekacin suppliers with USDMF on PharmaCompass.
Habekacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Habekacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Habekacin GMP manufacturer or Habekacin GMP API supplier for your needs.
A Habekacin CoA (Certificate of Analysis) is a formal document that attests to Habekacin's compliance with Habekacin specifications and serves as a tool for batch-level quality control.
Habekacin CoA mostly includes findings from lab analyses of a specific batch. For each Habekacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Habekacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Habekacin EP), Habekacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Habekacin USP).
LOOKING FOR A SUPPLIER?
